We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$5.67B
AUM Growth
+$449M
Cap. Flow
+$100M
Cap. Flow %
1.77%
Top 10 Hldgs %
21.33%
Holding
617
New
29
Increased
183
Reduced
116
Closed
41

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$44.1M
2
ACGL icon
Arch Capital
ACGL
+$36.2M
3
XYL icon
Xylem
XYL
+$35.6M
4
AME icon
Ametek
AME
+$12M
5
GWW icon
W.W. Grainger
GWW
+$11.2M

Top Sells

Rank Stock Value
1
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$37.3M
2
PGR icon
Progressive
PGR
+$31.7M
3
INTU icon
Intuit
INTU
+$31.1M
4
VSXY
Victoria's Secret
VSXY
+$30.2M
5
NVDA icon
NVIDIA
NVDA
+$9.01M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 19.27%
3 Consumer Discretionary 10.8%
4 Industrials 9.16%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
376
Pacific Biosciences
PACB
$435M
$833K 0.01%
63,500
-35,000
-36% -$425K
OCUL icon
377
Ocular Therapeutix
OCUL
$1.79B
$805K 0.01%
158,800
– –
AXSM icon
378
Axsome Therapeutics
AXSM
$11.2B
$804K 0.01%
11,000
– –
DCBO
379
Docebo
DCBO
$525M
$804K 0.01%
20,900
– –
NTR icon
380
Nutrien
NTR
$33.2B
$797K 0.01%
13,500
+5,400
+67% +$344K
BDX icon
381
Becton Dickinson
BDX
$45.6B
$793K 0.01%
3,042
+514
+20% +$131K
DNLI icon
382
Denali Therapeutics
DNLI
$3.65B
$790K 0.01%
26,900
– –
GPRK icon
383
GeoPark
GPRK
$633M
$788K 0.01%
80,000
– –
FNV icon
384
Franco-Nevada
FNV
$41.1B
$780K 0.01%
5,611
+5,400
+2,559% +$810K
VIR icon
385
Vir Biotechnology
VIR
$1.46B
$719K 0.01%
28,800
– –
SQM icon
386
Sociedad Química y Minera de Chile
SQM
$19.2B
$715K 0.01%
10,000
– –
RARE icon
387
Ultragenyx Pharmaceutical
RARE
$2.45B
$700K 0.01%
15,010
– –
PRU icon
388
Prudential Financial
PRU
$42.4B
$697K 0.01%
7,932
-40,445
-84% -$3.38M
BOX icon
389
Box
BOX
$4.37B
$694K 0.01%
23,900
– –
HIG icon
390
Hartford Financial Services
HIG
$38.9B
$692K 0.01%
9,700
– –
BEAM icon
391
Beam Therapeutics
BEAM
$2.63B
$690K 0.01%
21,700
– –
CE icon
392
Celanese
CE
$4.9B
$685K 0.01%
6,000
+1,500
+33% +$163K
LEGN icon
393
Legend Biotech
LEGN
$3.59B
$681K 0.01%
9,700
– –
TME icon
394
Tencent Music
TME
$15.5B
$664K 0.01%
90,000
– –
ELV icon
395
Elevance Health
ELV
$81.5B
$656K 0.01%
1,489
-7,141
-83% -$3.29M
RRX icon
396
Regal Rexnord
RRX
$13.7B
$650K 0.01%
4,295
+1,871
+77% +$255K
DAWN
397
DELISTED
Day One Biopharmaceuticals
DAWN
$628K 0.01%
51,200
– –
KRYS icon
398
Krystal Biotech
KRYS
$10.1B
$625K 0.01%
5,400
– –
KYMR icon
399
Kymera Therapeutics
KYMR
$8.51B
$605K 0.01%
27,000
– –
CYTK icon
400
Cytokinetics
CYTK
$10.5B
$604K 0.01%
18,450
– –
14 15
16
17 18

Similar funds

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Erste Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Erste Asset Management held 617 positions worth $5.67B, up 8.6% from $5.22B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Erste Asset Management's Q2 2023 filing shows 29 new, 183 increased, 116 reduced and 41 closed positions. Its largest new stake was UiPath: 660,000 shares worth $11M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2023 buy was UiPath: 660,000 shares worth $11M.
  • Erste Asset Management added most to AstraZeneca in Q2 2023, an estimated $44.1M increase.
  • Erste Asset Management's biggest Q2 2023 reduction was Progressive, cutting an estimated $31.7M.
  • Erste Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $37.3M.
  • Erste Asset Management's ten largest holdings make up 21% of its $5.67B portfolio in Q2 2023.
  • Erste Asset Management opened 29 new positions and closed 41 in Q2 2023.
  • Erste Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.67B.

Based on Erste Asset Management's 13F filing for Q2 2023, filed 26 Nov 2024.